Singh K, Mogare D, Giridharagopalan RO, Gogiraju R, Pande G, Chattopadhyay S. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion. PLoS ONE. 2007;2(7):e660.
Noronha G, Barrett K, Boccia A, et al. Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine–a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays. Bioorg Med Chem Lett. 2007;17(3):602-8.
Targeting Drug Resistant Mutations Using Novel Binding Interactions – Lessons Learned from Abl-T315I and their Implications in Drug Design . Frontiers in Drug Design & Discovery: Structure-Based Drug Design in the 21st Century
Das C, Hizume K, Batta K, et al. Transcriptional coactivator PC4, a chromatin-associated protein, induces chromatin condensation. Mol Cell Biol. 2006;26(22):8303-15.
Balasubramanyam K, Altaf M, Varier RA, et al. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem. 2004;279(32):33716-26.
Pillai B, Verma J, Abraham A, et al. Whole genome expression profiles of yeast RNA polymerase II core subunit, Rpb4, in stress and nonstress conditions. J Biol Chem. 2003;278(5):3339-46.
Genome-wide expression profile of RNA polymerase II subunit mutant of yeast using microarray technology
Lvovsky L, Ioshikhes I, Raja MC, et al. Interdependence between DNA template secondary structure and priming efficiencies of short primers. Nucleic Acids Res. 1998;26(23):5525-32.